摘要
目的:探讨黛力新联合胃动力治疗对患者胃肌电及临床症状的影响。方法:随机选取2010年8月至2013年8月我院收治的110例功能性消化不良患者,依据随机数字表法分这些患者为两组,即研究组(n=55)和对照组(n=55)。给予研究组患者黛力新联合胃动力治疗,给予对照组患者莫沙必利治疗,然后对两组患者的餐前和餐后胃电慢波百分比及临床症状积分、临床疗效及不良反应发生情况进行统计分析。结果:研究组患者的餐后胃电慢波百分比显著高于对照组(P<0.05),临床症状积分显著低于对照组(P<0.05),治疗的总有效率87.3%(48/55)显著高于对照组61.8%(34/55)(P<0.05),不良反应发生率5.5%(3/55)显著低于对照组18.2%(10/55)(P<0.05)。结论:黛力新联合胃动力治疗能够有效改善功能性消化不良患者胃肌电及临床症状,提高对患者治疗的总有效率,并降低患者的不良反应发生率,安全有效,值得在临床推广。
Objective：To investigate the influences of deanxit joint motility therapy on patients＇ gastric myoelectric and clinical symptoms.Methods：110 cases of patientsfunctional dyspepsia in our hospital from August 2010 to August2013 were randomly selected,these patients were divided into two groups based on the random number table,the study group（n=55） and control group（n=55）.The study group were given the new treatment of deanxit joint motility,while the control group were given mosapride,and then the fasting and postprandial gastric electrical slow wave percentage and clinical symptom score,clinical efficacy and adverse events of the two groups were statistically analyzed.Results：The postprandial gastric electrical slow wave percentage of the study group was significantly higher（P〈0.05）,the clinical symptom score was significantly lower（P〈0.05）,the total treatment efficiency 87.3%（48/55） was significantly higher than the control group 61.8%（34/55）（P〈0.05）,the incidence of adverse reactions 5.5%（3/55）was significantly lower than the control group 18.2%（10/55）（P〈0.05）.Conclusion：Deanxit joint motility therapy can improve the gastric myoelectric and clinical symptoms,improve the overall efficiency,and reduce the incidence of adverse reactions of patients with functional dyspepsia,it is safe and effective,so is worthy of promoting in the clinical.
出处
《黑龙江医药》
CAS
2015年第5期1073-1075,共3页
Heilongjiang Medicine journal
关键词
黛力新联合胃动力
胃肌电
临床症状
影响
Deanxit joint motility
Gastric myoelectric
Clinical symptoms
Influence
